Haura EB - Search Results

1

Phase I/Ib Study of Pembrolizumab Plus Vorinostat in Advanced/Metastatic Non-Small Cell Lung Cancer.

Gray JE, Saltos A, Tanvetyanon T, Haura EB, Creelan B, Antonia SJ, Shafique M, Zheng H, Dai W, Saller JJ, Chen Z, Tchekmedyian N, Goas K, Thapa R, Boyle TA, Chen DT, Beg AA. Gray JE, et al. Among authors: haura eb. Clin Cancer Res. 2019 Nov 15;25(22):6623-6632. doi: 10.1158/1078-0432.CCR-19-1305. Epub 2019 Aug 13. Clin Cancer Res. 2019. PMID: 31409616 Free PMC article. Clinical Trial.

2

Treatment of advanced non-small-cell lung cancer: a review of current randomized clinical trials and an examination of emerging therapies.

Haura EB. Haura EB. Cancer Control. 2001 Jul-Aug;8(4):326-36. doi: 10.1177/107327480100800404. Cancer Control. 2001. PMID: 11483886 Free article. Review.

3

Management of advanced non-small cell lung cancer: current trends.

Haura EB. Haura EB. Curr Opin Pulm Med. 2002 Jul;8(4):251-6. doi: 10.1097/00063198-200207000-00002. Curr Opin Pulm Med. 2002. PMID: 12055385 Review.

4

Gene therapy for lung cancer. An introduction.

Haura EB, Sotomayor E, Antonia SJ. Haura EB, et al. Methods Mol Med. 2003;75:529-43. doi: 10.1385/1-59259-324-0:529. Methods Mol Med. 2003. PMID: 12407762 Review.

5

Gene therapy for lung cancer.

Haura EB, Sotomayor E, Antonia SJ. Haura EB, et al. Mol Biotechnol. 2003 Oct;25(2):139-48. doi: 10.1385/MB:25:2:139. Mol Biotechnol. 2003. PMID: 14526124 Review.

6

Gefitinib (ZD1839) in previously treated advanced non-small-cell lung cancer: experience from a single institution.

Simon GR, Ruckdeschel JC, Williams C, Cantor A, Chiappori A, Rocha Lima CM, Antonia S, Haura E, Wagner H, Robinson L, Sommers E, Alberts M, Bepler G. Simon GR, et al. Cancer Control. 2003 Sep-Oct;10(5):388-95. doi: 10.1177/107327480301000506. Cancer Control. 2003. PMID: 14581894 Free article. Clinical Trial.

7

Neutropenic enterocolitis (typhilitis) associated with docetaxel therapy in a patient with non-small-cell lung cancer: case report and review of literature.

D'Amato G, Rocha Lima C, Mahany JJ, Muro-Cacho C, Haura EB. D'Amato G, et al. Among authors: haura eb. Lung Cancer. 2004 Jun;44(3):381-90. doi: 10.1016/j.lungcan.2003.11.018. Lung Cancer. 2004. PMID: 15140552 Review.

8

RRM1 and PTEN as prognostic parameters for overall and disease-free survival in patients with non-small-cell lung cancer.

Bepler G, Sharma S, Cantor A, Gautam A, Haura E, Simon G, Sharma A, Sommers E, Robinson L. Bepler G, et al. J Clin Oncol. 2004 May 15;22(10):1878-85. doi: 10.1200/JCO.2004.12.002. J Clin Oncol. 2004. PMID: 15143080

9

Antiapoptotic signaling pathways in non-small-cell lung cancer: biology and therapeutic strategies.

Haura EB, Cress WD, Chellappan S, Zheng Z, Bepler G. Haura EB, et al. Clin Lung Cancer. 2004 Sep;6(2):113-22. doi: 10.3816/CLC.2004.n.025. Clin Lung Cancer. 2004. PMID: 15476597 Review.

10

Mcl-1 regulates survival and sensitivity to diverse apoptotic stimuli in human non-small cell lung cancer cells.

Song L, Coppola D, Livingston S, Cress D, Haura EB. Song L, et al. Among authors: haura eb. Cancer Biol Ther. 2005 Mar;4(3):267-76. doi: 10.4161/cbt.4.3.1496. Epub 2005 Mar 20. Cancer Biol Ther. 2005. PMID: 15753661 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

247 results

Search Page

Filters